BBIO
BridgeBio Pharma Inc
BridgeBio Pharma Inc 13F Holders
BBIO Stock Ownership Activity
- # of activities:
- 1
- AVG reported price*:
- $26.97
- Current price*:
- +213.55%($84.56)
1 value investing guru has made changes to the BridgeBio Pharma Inc (BBIO) position according to the gurus' 2019 Q2 SEC quarterly report(s). BBIO has been bought (as a new position) by 1 guru(s)
Which gurus or hedge funds bought BBIO in 2019 Q2?
According to the 2019 Q2 SEC filing(s) BridgeBio Pharma Inc (BBIO) has been bought by Ole Andreas Halvorsen - Viking Global Investors (new buy).
To see more about who is investing in BridgeBio Pharma Inc (BBIO), please go to the BBIO ownership page.
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Current price: this can be a delayed price and may not reflect the real-time market value, however it is too close.
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* AVG reported price: weighted average based on position sizes. Larger holdings have proportionally more influence on the average. This doesn't represent the actual buy or sell price. It is the split-adjusted average price of the securities as of the last day of the reported period.
* Held since / Held for: calculated since the latest "new buy" position. If the security was previously exited and re-entered, only the most recent holding period is counted.